Phathom Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/14/2025 | 12.47 M | $119.55 M | 23.32% | 17.20% |
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 07/08/2025 | 7.46 M | $71.59 M | 0.00% | 10.30% |
INVESCO LTD. | 08/13/2025 | 4.14 M | $39.70 M | 13.40% | 5.71% |
CARLYLE GROUP INC. | 08/08/2025 | 3.50 M | $33.53 M | 0.00% | 4.83% |
BLACKROCK, INC. | 08/12/2025 | 3.32 M | $31.79 M | -0.25% | 4.58% |
VANGUARD GROUP INC | 08/11/2025 | 2.79 M | $26.73 M | 0.31% | 3.85% |
ENSIGN PEAK ADVISORS, INC | 08/12/2025 | 2.52 M | $24.17 M | 0.23% | 3.48% |
MILLENNIUM MANAGEMENT LLC | 08/14/2025 | 2.25 M | $21.58 M | 330.01% | 3.11% |
683 CAPITAL MANAGEMENT, LLC | 08/14/2025 | 2.11 M | $20.19 M | 45.67% | 2.90% |
NEA MANAGEMENT COMPANY, LLC | 08/14/2025 | 1.96 M | $18.80 M | 0.00% | 2.70% |
WASATCH ADVISORS LP | 08/14/2025 | 1.46 M | $14.02 M | -14.09% | 2.02% |
CATALYS PACIFIC, LLC | 08/13/2025 | 1.17 M | $11.19 M | 0.00% | 1.61% |
GEODE CAPITAL MANAGEMENT, LLC | 08/08/2025 | 1.07 M | $10.26 M | 5.26% | 1.48% |
AVIDITY PARTNERS MANAGEMENT LP | 08/14/2025 | 1.06 M | $10.21 M | 33.06% | 1.47% |
GW&K INVESTMENT MANAGEMENT, LLC | 08/11/2025 | 1.05 M | $10.06 M | -5.06% | 1.45% |
PROPEL BIO MANAGEMENT, LLC | 08/13/2025 | 922.93 K | $8.85 M | -18.68% | 1.27% |
STATE STREET CORP | 08/14/2025 | 849.42 K | $8.15 M | -5.76% | 1.17% |
CATALIO CAPITAL MANAGEMENT, LP | 08/14/2025 | 672.29 K | $6.45 M | 100.00% | 0.93% |
MOORE CAPITAL MANAGEMENT, LP | 08/14/2025 | 600.00 K | $5.75 M | 100.00% | 0.83% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2025 | 554.90 K | $5.32 M | 1,731.35% | 0.77% |
SIMPLIFY ASSET MANAGEMENT INC. | 08/07/2025 | 521.94 K | $5.01 M | -23.46% | 0.72% |
CITIGROUP INC | 08/11/2025 | 517.25 K | $4.96 M | -2.56% | 0.71% |
CAPTION MANAGEMENT, LLC | 08/14/2025 | 435.00 K | $4.17 M | 100.00% | 0.60% |
STEPSTONE GROUP LP | 08/13/2025 | 422.09 K | $4.05 M | 0.00% | 0.58% |
UBS GROUP AG | 08/14/2025 | 419.47 K | $4.02 M | -40.72% | 0.58% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2025 | 404.60 K | $3.88 M | 2,052.13% | 0.56% |
CAPTION MANAGEMENT, LLC | 08/14/2025 | 380.10 K | $3.65 M | 100.00% | 0.52% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2025 | 360.16 K | $3.45 M | 3.48% | 0.50% |
NORTHERN TRUST CORP | 08/13/2025 | 359.32 K | $3.45 M | -7.06% | 0.50% |
SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2025 | 306.40 K | $2.94 M | 100.00% | 0.42% |
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 08/14/2025 | 267.96 K | $2.57 M | 100.00% | 0.37% |
JANE STREET GROUP, LLC | 08/14/2025 | 208.20 K | $2.00 M | 1,941.18% | 0.29% |
WOODLINE PARTNERS LP | 08/14/2025 | 187.29 K | $1.80 M | -75.08% | 0.26% |
AMERIPRISE FINANCIAL INC | 08/14/2025 | 180.85 K | $1.73 M | 100.00% | 0.25% |
ROYAL BANK OF CANADA | 08/14/2025 | 157.94 K | $1.52 M | 1,451.18% | 0.22% |
HAP TRADING, LLC | 08/13/2025 | 150.00 K | $90 | 100.00% | 0.21% |
JANE STREET GROUP, LLC | 08/14/2025 | 138.70 K | $1.33 M | 100.00% | 0.19% |
JPMORGAN CHASE & CO | 08/12/2025 | 138.52 K | $1.33 M | 0.82% | 0.19% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2025 | 134.21 K | $1.29 M | -16.71% | 0.19% |
BANK OF NEW YORK MELLON CORP | 08/05/2025 | 121.17 K | $1.16 M | 5.79% | 0.17% |
NUVEEN, LLC | 08/12/2025 | 110.11 K | $1.06 M | 8.46% | 0.15% |
BANK OF AMERICA CORP /DE/ | 08/14/2025 | 96.08 K | $921.41 K | -43.58% | 0.13% |
STATE OF WISCONSIN INVESTMENT BOARD | 08/14/2025 | 90.78 K | $870.59 K | -9.02% | 0.13% |
BARCLAYS PLC | 08/14/2025 | 82.17 K | $788.00 K | 49.67% | 0.11% |
RHUMBLINE ADVISERS | 08/12/2025 | 64.56 K | $619.09 K | 13.78% | 0.09% |
ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2025 | 63.42 K | $608.24 K | 48.19% | 0.09% |
PENN MUTUAL ASSET MANAGEMENT, LLC | 08/14/2025 | 62.80 K | $602.27 K | 0.00% | 0.09% |
CREATIVE PLANNING | 08/08/2025 | 57.26 K | $549.16 K | -4.46% | 0.08% |
WELLS FARGO & COMPANY/MN | 08/14/2025 | 46.68 K | $447.64 K | 64.21% | 0.06% |
VIRTUS INVESTMENT ADVISERS, INC. | 08/13/2025 | 44.31 K | $424.90 K | -1.46% | 0.06% |
Phathom Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 166 institutional investors and hedge funds held shares of Phathom Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Medicxi Ventures Management (Jersey) Ltd: 7.46 M
Simplify Asset Management Inc.: 321,935
INSPIRION WEALTH ADVISORS, LLC: 36,634
Summit Financial Wealth Advisors, LLC: 22,143
CWM, LLC: 1,968
GAMMA Investing LLC: 360
78.61% of Phathom Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 63.73 M shares in the last 24 months. This purchase volume represents approximately $892.19 M in transactions.